Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
- 7 April 2000
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (7) , 1570-1593
- https://doi.org/10.1200/jco.2000.18.7.1570
Abstract
Many therapeutic regimens in cancer treatment carry the risk of causing or favoring the development of osteoporosis. Therapies in which hypogonadism may occur are most relevant in this re...Keywords
This publication has 266 references indexed in Scilit:
- The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinomaCancer, 1998
- New endocrine therapies for breast cancerEuropean Journal Of Cancer, 1996
- Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphomaAnnals of Hematology, 1994
- The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in ratsCalcified Tissue International, 1993
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and functionReproductive Toxicology, 1992
- Long-term thyroxine treatment and bone mineral densityThe Lancet, 1992
- Bone mineral density (BMD) in patients with lymphoma: The effects of chemotherapy, intermittent corticosteroids and premature menopauseHematological Oncology, 1992
- Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumorThe Journal of Pediatrics, 1990
- Effects of cisplatin and bleomycin on mature rat leydig cell testosterone productionJournal of Steroid Biochemistry, 1988